Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BY-NCChemical and Pharmaceutical Bulletin

Influence of pH, Alcohol Structure, and Temperature on Lenalidomide Alcoholysis with Implications for Pharmaceutical Quality Control

Abstract

Artifacts generated during sample preparation or analysis can compromise impurity evaluation in pharmaceutical quality control. Lenalidomide, a thalidomide derivative used for multiple myeloma treatment and as a cereblon ligand in a proteolysis-targeting chimera (PROTAC), undergoes methanolysis through ring opening of its glutarimide moiety, forming constitutional isomers. This study systematically evaluated the alcoholysis of lenalidomide under various pH, methanol (MeOH) concentration, temperature, and alcohol conditions to clarify key factors affecting artifact formation. Stress studies showed that the total amount of methanolysis products exhibited linear relationships with pH, MeOH concentration, and temperature after log transformation. Kinetic modeling indicated that pH had the strongest effect on degradation, followed by MeOH concentration and temperature. The reaction was markedly accelerated under basic conditions, likely due to nucleophilic attack by methoxide ions. Evaluation of monohydric alcohols revealed that MeOH produced the greatest amount of alcoholysis products, whereas longer-chain and branched alcohols showed lower reactivity. In particular, 2-propanol effectively suppressed product formation, probably because of steric hindrance. These results demonstrate the importance of controlling pH and solvent composition during analysis to minimize artifact formation. The findings provide practical strategies for improving impurity assessment methods for lenalidomide and related thalidomide derivatives, including cereblon-recruiting PROTACs.

Related

  1. Gaps, challenges, and opportunities of sodium borohydride alcoholysis for hydrogen
    Enzo Catapano, Umit Demirci
    International Journal of Hydrogen EnergyPeer-reviewedPublisher termsFull text12 citedMaterials & polymersHAL
  2. Influence of temperature and strain rate on the competition between dynamic precipitation and dynamic dissolution in an aged 7xxx Aluminum alloy
    Guillaume Crowin, Frédéric De Geuser, Arthur Després +1
    Acta MaterialiaPeer-reviewedCC BY 4.0Full text6 citedMaterials & polymersHALOpenAlex
  3. Influence of Temperature and Osmolytes on Conformational Dynamics of Alpha Synuclein.
    Jared Hampton, Cameron Lynch, Robert L Rider +3
    The journal of physical chemistry. BPeer-reviewedCC BYFull textPhysical chemistryEurope PMCPMC
  4. Sequential Alcoholysis–Esterification Catalysis by Immobilized Lipases for the Synthesis of OPO Structured Lipids: Immobilization Methods, Carriers, and Prospects
    Jinlan Tu, Yani Zhao, Qiongya Lu +5
    CatalystsPeer-reviewedCC BY 4.0CatalysisCrossref
  5. The Influence of Rheological Properties on the Adhesiveness of Food Waste and Its Implications for Mechanical Separation
    Panida Payomthip, Noppharit Sutthasil, Hiroyuki Ishimori +2
    ACS OmegaPeer-reviewedCC BY-NC-ND 4.0Full textGeneral chemistryCrossrefEurope PMC
BibTeX
@article{miyazaki2026influence,
  title = {{Influence of pH, Alcohol Structure, and Temperature on Lenalidomide Alcoholysis with Implications for Pharmaceutical Quality Control}},
  author = {Keisuke Miyazaki and Kousuke Tamura and Eiji Obara and Nobuyuki Suzuki},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2026},
  month = aug,
  doi = {10.1248/cpb.c26-00244},
  url = {https://www.jstage.jst.go.jp/article/cpb/74/8/74_c26-00244/_article},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Influence of pH, Alcohol Structure, and Temperature on Lenalidomide Alcoholysis with Implications for Pharmaceutical Quality Control
AU  - Keisuke Miyazaki
AU  - Kousuke Tamura
AU  - Eiji Obara
AU  - Nobuyuki Suzuki
PY  - 2026
DA  - 2026/08/25
JO  - Chemical and Pharmaceutical Bulletin
DO  - 10.1248/cpb.c26-00244
UR  - https://www.jstage.jst.go.jp/article/cpb/74/8/74_c26-00244/_article
AB  - Artifacts generated during sample preparation or analysis can compromise impurity evaluation in pharmaceutical quality control. Lenalidomide, a thalidomide derivative used for multiple myeloma treatment and as a cereblon ligand in a proteolysis-targeting chimera (PROTAC), undergoes methanolysis through ring opening of its glutarimide moiety, forming constitutional isomers. This study systematically evaluated the alcoholysis of lenalidomide under various pH, methanol (MeOH) concentration, temperature, and alcohol conditions to clarify key factors affecting artifact formation. Stress studies showed that the total amount of methanolysis products exhibited linear relationships with pH, MeOH concentration, and temperature after log transformation. Kinetic modeling indicated that pH had the strongest effect on degradation, followed by MeOH concentration and temperature. The reaction was markedly accelerated under basic conditions, likely due to nucleophilic attack by methoxide ions. Evaluation of monohydric alcohols revealed that MeOH produced the greatest amount of alcoholysis products, whereas longer-chain and branched alcohols showed lower reactivity. In particular, 2-propanol effectively suppressed product formation, probably because of steric hindrance. These results demonstrate the importance of controlling pH and solvent composition during analysis to minimize artifact formation. The findings provide practical strategies for improving impurity assessment methods for lenalidomide and related thalidomide derivatives, including cereblon-recruiting PROTACs.
SN  - 1347-5223
SN  - 0009-2363
ER  -